Ionis Pharmaceuticals (IONS) Net Cash Flow (2009 - 2026)
Ionis Pharmaceuticals (IONS) posted quarterly Net Cash Flow of $176.7 million for Q2 2026, up 443.51% year-over-year from $32.5 million in Q2 2025, and up 188.93% quarter-over-quarter from -$198.7 million in Q1 2026.
Ionis Pharmaceuticals (IONS) Net Cash Flow (2009 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Net Cash Flow history runs 18 years deep, the most recent figure standing at $176.7 million for Q2 2026.
- In Q2 2026, Net Cash Flow rose 443.51% year-over-year to $176.7 million; the TTM figure through Jun 2026 stood at $53.1 million (up 1925.73% YoY), while the FY2025 annual figure was $129.5 million, up 182.52% from the prior year.
- Net Cash Flow for Q2 2026 stood at $176.7 million, up from -$198.7 million in the prior quarter.
- The five-year high for Net Cash Flow was $176.7 million in Q2 2026, with the low at -$326.5 million in Q1 2022.
- The 5-year median for Net Cash Flow is $849000.0 (2022), against an average of -$28.9 million.
- The sharpest annual moves came in 2022 and 2023: Net Cash Flow plunged 2065.0% in 2022, then jumped 673.14% in 2023.
- Ionis Pharmaceuticals' Net Cash Flow stood at -$39.1 million in 2022, then soared by 219.99% to $46.9 million in 2023, then plunged by 296.35% to -$92.0 million in 2024, then jumped by 136.9% to $34.0 million in 2025, then soared by 420.39% to $176.7 million in 2026.
- Business Quant data shows IONS's Net Cash Flow at $176.7 million in Q2 2026, -$198.7 million in Q1 2026, and $34.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 407.41 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 17.81 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -496,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.14 Mn |
| 10 | Ionis Pharmaceuticals | 9.48 Bn | 7.43 Bn | 265.21 Mn | 176.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 176.73 Mn |
| Jun 30, 2026 | 176.73 Mn |
| Mar 31, 2026 | -198.74 Mn |
| Mar 31, 2026 | -198.74 Mn |
| Dec 31, 2025 | 33.96 Mn |
| Dec 31, 2025 | 33.96 Mn |
| Sep 30, 2025 | 41.12 Mn |
| Sep 30, 2025 | 41.12 Mn |
| Jun 30, 2025 | 32.52 Mn |
| Jun 30, 2025 | 32.52 Mn |
| Mar 31, 2025 | 21.88 Mn |
| Mar 31, 2025 | 21.88 Mn |
| Dec 31, 2024 | -92.04 Mn |
| Dec 31, 2024 | -92.04 Mn |
| Sep 30, 2024 | 40.26 Mn |
| Sep 30, 2024 | 40.26 Mn |
| Jun 30, 2024 | -54.87 Mn |
| Jun 30, 2024 | -54.87 Mn |
| Mar 31, 2024 | -50.26 Mn |
| Mar 31, 2024 | -50.26 Mn |